Agenus | AGEN - Cost Of Sales

Agenus reported $308K in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Abbvie ABBV:US USD 4.17B 57M
Agenus AGEN:US USD 308K 1.72M
Amgen AMGN:US USD 1.75B 159M
AstraZeneca AZN:LN USD 2.51B 393M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Dynavax Technologies DVAX:US USD 77.49M 16.15M
Eli Lilly And LLY:US USD 1.55B 31M
Gilead Sciences GILD:US USD 1.4B 1000K
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Glaxosmithkline GSK:US GBP 2.18B 209M
Intrexon XON:US USD 1.58M 234K
Jiangsu Hengrui Me. 600276:CH CNY 980.82M 148.19M
Johnson & Johnson JNJ:US USD 7.76B 29M
Karyopharm Therapeutics KPTI:US USD 1.87M 888K
MacroGenics MGNX:US USD 3.14M 741K
Merck MRK:GR EUR 2.15B 38M
Merk MRK:US USD 3.36B 519M
Novartis NOVN:VX USD 3.84B 180M
Novavax NVAX:US USD 181.76M 252.83M
Pfizer PFE:US USD 9.82B 3.73B
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Rigel Pharmaceuticals RIGL:US USD 250K 786K
Veracyte VCYT:US USD 26.83M 823K
YTE INCY:US USD 53.76M 4.48M